Markel Group Inc. (MKL)

Executive Summary

Markel Group is what we politely call the “Baby Berkshire” — a three-legged compounder built around specialty insurance, controlled operating businesses housed in Markel Ventures, and a large public-equity portfolio managed for two decades by Tom Gayner. The stock has compounded book value per share at roughly 10 percent annually over the last decade. It is also, at $1,858, one of the more interesting special situations in the broader financial-services complex today because an activist with a credible playbook and a track record of forcing structural change has put the company under public review.

What’s Inside The Full Report

• 15-year financial summary table — revenue, net income, GAAP & adjusted EPS
• Valuation framework — current multiples vs. 5-year historical range
• Peer comparison table — multiples, margins, balance-sheet metrics
• Base case, bull case, bear case price targets with explicit math
• Competitive position and economic moat analysis
• Management and capital allocation track record
• Balance sheet review — leverage, credit ratings, distribution coverage
• Insider activity — recent open-market buys / sells with interpretation
• Strategic acquisitions and divestitures history
• Sell-side consensus and where TTCM differs
• Detailed risk factors specific to the name
• Bull case and forward catalysts to watch
• TTCM rating with explicit ADD / TRIM price triggers